| UniProt ID | PARP9_HUMAN | |
|---|---|---|
| UniProt AC | Q8IXQ6 | |
| Protein Name | Poly [ADP-ribose] polymerase 9 | |
| Gene Name | PARP9 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 854 | |
| Subcellular Localization | Cytoplasm, cytosol . Nucleus . Shuttles between the nucleus and the cytosol (PubMed:16809771). Translocates to the nucleus in response to IFNG or IFNB1 stimulation (PubMed:26479788). Export to the cytosol depends on the interaction with DTX3L (PubMed | |
| Protein Description | ADP-ribosyltransferase which, in association with E3 ligase DTX3L, plays a role in DNA damage repair and in immune responses including interferon-mediated antiviral defenses. [PubMed: 16809771] | |
| Protein Sequence | MDFSMVAGAAAYNEKSGRITSLSLLFQKVFAQIFPQWRKGNTEECLPYKCSETGALGENYSWQIPINHNDFKILKNNERQLCEVLQNKFGCISTLVSPVQEGNSKSLQVFRKMLTPRIELSVWKDDLTTHAVDAVVNAANEDLLHGGGLALALVKAGGFEIQEESKQFVARYGKVSAGEIAVTGAGRLPCKQIIHAVGPRWMEWDKQGCTGKLQRAIVSILNYVIYKNTHIKTVAIPALSSGIFQFPLNLCTKTIVETIRVSLQGKPMMSNLKEIHLVSNEDPTVAAFKAASEFILGKSELGQETTPSFNAMVVNNLTLQIVQGHIEWQTADVIVNSVNPHDITVGPVAKSILQQAGVEMKSEFLATKAKQFQRSQLVLVTKGFNLFCKYIYHVLWHSEFPKPQILKHAMKECLEKCIEQNITSISFPALGTGNMEIKKETAAEILFDEVLTFAKDHVKHQLTVKFVIFPTDLEIYKAFSSEMAKRSKMLSLNNYSVPQSTREEKRENGLEARSPAINLMGFNVEEMYEAHAWIQRILSLQNHHIIENNHILYLGRKEHDILSQLQKTSSVSITEIISPGRTELEIEGARADLIEVVMNIEDMLCKVQEEMARKKERGLWRSLGQWTIQQQKTQDEMKENIIFLKCPVPPTQELLDQKKQFEKCGLQVLKVEKIDNEVLMAAFQRKKKMMEEKLHRQPVSHRLFQQVPYQFCNVVCRVGFQRMYSTPCDPKYGAGIYFTKNLKNLAEKAKKISAADKLIYVFEAEVLTGFFCQGHPLNIVPPPLSPGAIDGHDSVVDNVSSPETFVIFSGMQAIPQYLWTCTQEYVQSQDYSSGPMRPFAQHPWRGFASGSPVD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 4 | Phosphorylation | ----MDFSMVAGAAA ----CCHHHHCCHHH | 14.21 | 25850435 | |
| 12 | Phosphorylation | MVAGAAAYNEKSGRI HHCCHHHCCCCCCCC | 21.09 | 25850435 | |
| 18 (in isoform 2) | Phosphorylation | - | 35.78 | 27251275 | |
| 49 | Ubiquitination | TEECLPYKCSETGAL CCCCCCEECCCCCCC | 29.37 | - | |
| 51 | Phosphorylation | ECLPYKCSETGALGE CCCCEECCCCCCCCC | 33.76 | 27251275 | |
| 53 | Phosphorylation | LPYKCSETGALGENY CCEECCCCCCCCCCE | 16.09 | 27251275 | |
| 61 | Phosphorylation | GALGENYSWQIPINH CCCCCCEEEEEECCC | 24.88 | 24247654 | |
| 72 | Ubiquitination | PINHNDFKILKNNER ECCCCCCHHHCCCHH | 50.41 | - | |
| 75 | Ubiquitination | HNDFKILKNNERQLC CCCCHHHCCCHHHHH | 62.29 | - | |
| 88 | Ubiquitination | LCEVLQNKFGCISTL HHHHHHHHCCHHHCC | 30.12 | - | |
| 105 | Ubiquitination | PVQEGNSKSLQVFRK CCCCCCCCHHHHHHH | 60.22 | - | |
| 121 | Phosphorylation | LTPRIELSVWKDDLT HCCCEEEEEECCHHH | 17.09 | 22496350 | |
| 166 | Ubiquitination | FEIQEESKQFVARYG CCCCHHHHHHHHHHC | 51.54 | - | |
| 172 | Phosphorylation | SKQFVARYGKVSAGE HHHHHHHHCCCCHHE | 16.15 | 22817900 | |
| 174 | Ubiquitination | QFVARYGKVSAGEIA HHHHHHCCCCHHEEE | 24.87 | - | |
| 191 | Ubiquitination | GAGRLPCKQIIHAVG CCCCCCHHHHHHHHC | 42.46 | - | |
| 206 | Ubiquitination | PRWMEWDKQGCTGKL CCHHCCCCCCCCHHH | 50.06 | - | |
| 273 | Ubiquitination | KPMMSNLKEIHLVSN CCCCCCCEEEEEECC | 59.89 | - | |
| 279 | Phosphorylation | LKEIHLVSNEDPTVA CEEEEEECCCCHHHH | 40.64 | 22210691 | |
| 289 | Ubiquitination | DPTVAAFKAASEFIL CHHHHHHHHHHHHHC | 38.01 | - | |
| 361 | Ubiquitination | QQAGVEMKSEFLATK HHHCCCHHHHHHHHH | 33.07 | - | |
| 362 | Phosphorylation | QAGVEMKSEFLATKA HHCCCHHHHHHHHHH | 32.07 | 24719451 | |
| 368 | Ubiquitination | KSEFLATKAKQFQRS HHHHHHHHHHHHCHH | 48.24 | - | |
| 368 | Malonylation | KSEFLATKAKQFQRS HHHHHHHHHHHHCHH | 48.24 | 32601280 | |
| 411 | Ubiquitination | QILKHAMKECLEKCI HHHHHHHHHHHHHHH | 46.16 | - | |
| 455 | Ubiquitination | DEVLTFAKDHVKHQL HHHHHHHHHHHHCCE | 44.14 | - | |
| 459 | Ubiquitination | TFAKDHVKHQLTVKF HHHHHHHHCCEEEEE | 23.39 | - | |
| 477 | Ubiquitination | PTDLEIYKAFSSEMA ECCHHHHHHHCHHHH | 48.92 | - | |
| 485 | Ubiquitination | AFSSEMAKRSKMLSL HHCHHHHHHHCCCCC | 56.76 | - | |
| 487 | Phosphorylation | SSEMAKRSKMLSLNN CHHHHHHHCCCCCCC | 23.01 | 28634298 | |
| 488 | Ubiquitination | SEMAKRSKMLSLNNY HHHHHHHCCCCCCCC | 48.14 | - | |
| 491 | Phosphorylation | AKRSKMLSLNNYSVP HHHHCCCCCCCCCCC | 26.08 | 21945579 | |
| 495 | Phosphorylation | KMLSLNNYSVPQSTR CCCCCCCCCCCHHHH | 15.24 | 21945579 | |
| 496 | Phosphorylation | MLSLNNYSVPQSTRE CCCCCCCCCCHHHHH | 29.46 | 21945579 | |
| 500 | Phosphorylation | NNYSVPQSTREEKRE CCCCCCHHHHHHHHH | 24.30 | 21945579 | |
| 501 | Phosphorylation | NYSVPQSTREEKREN CCCCCHHHHHHHHHC | 36.53 | 21945579 | |
| 563 | Phosphorylation | RKEHDILSQLQKTSS CCHHHHHHHHHHCCC | 29.22 | 28122231 | |
| 569 | Phosphorylation | LSQLQKTSSVSITEI HHHHHHCCCCEEEEE | 35.46 | 28985074 | |
| 572 | Phosphorylation | LQKTSSVSITEIISP HHHCCCCEEEEEECC | 26.24 | 28985074 | |
| 574 | Phosphorylation | KTSSVSITEIISPGR HCCCCEEEEEECCCC | 17.39 | 28985074 | |
| 597 (in isoform 2) | Ubiquitination | - | 1.25 | 21890473 | |
| 627 | Phosphorylation | WRSLGQWTIQQQKTQ HHHHHHHHHHCCCCH | 10.87 | 28857561 | |
| 632 | Ubiquitination | QWTIQQQKTQDEMKE HHHHHCCCCHHHHHH | 43.76 | 21890473 | |
| 632 | Ubiquitination | QWTIQQQKTQDEMKE HHHHHCCCCHHHHHH | 43.76 | 21890473 | |
| 632 | Ubiquitination | QWTIQQQKTQDEMKE HHHHHCCCCHHHHHH | 43.76 | 21890473 | |
| 632 (in isoform 1) | Ubiquitination | - | 43.76 | 21890473 | |
| 637 | Sulfoxidation | QQKTQDEMKENIIFL CCCCHHHHHHCEEEE | 9.93 | 21406390 | |
| 638 | Ubiquitination | QKTQDEMKENIIFLK CCCHHHHHHCEEEEE | 45.63 | - | |
| 645 | Ubiquitination | KENIIFLKCPVPPTQ HHCEEEEECCCCCHH | 26.24 | - | |
| 651 | Phosphorylation | LKCPVPPTQELLDQK EECCCCCHHHHHHHH | 28.71 | 23532336 | |
| 659 | Ubiquitination | QELLDQKKQFEKCGL HHHHHHHHHHHHHCC | 55.37 | - | |
| 663 | Ubiquitination | DQKKQFEKCGLQVLK HHHHHHHHHCCEEEE | 34.59 | - | |
| 680 | Sulfoxidation | KIDNEVLMAAFQRKK ECCHHHHHHHHHHHH | 2.82 | 21406390 | |
| 693 | Acetylation | KKKMMEEKLHRQPVS HHHHHHHHHHCCCCH | 35.97 | 7355457 | |
| 705 (in isoform 2) | Ubiquitination | - | 48.21 | 21890473 | |
| 740 | Ubiquitination | GAGIYFTKNLKNLAE CCCEECCCCHHHHHH | 50.84 | 21890473 | |
| 740 | Ubiquitination | GAGIYFTKNLKNLAE CCCEECCCCHHHHHH | 50.84 | 21890473 | |
| 740 | Ubiquitination | GAGIYFTKNLKNLAE CCCEECCCCHHHHHH | 50.84 | 21890473 | |
| 740 (in isoform 1) | Ubiquitination | - | 50.84 | 21890473 | |
| 743 | Ubiquitination | IYFTKNLKNLAEKAK EECCCCHHHHHHHHH | 60.35 | - | |
| 849 | Phosphorylation | HPWRGFASGSPVD-- CCCCCCCCCCCCC-- | 37.23 | 23090842 | |
| 851 | Phosphorylation | WRGFASGSPVD---- CCCCCCCCCCC---- | 21.18 | 23403867 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PARP9_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PARP9_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PARP9_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| DTX3L_HUMAN | DTX3L | physical | 12670957 | |
| PARP1_HUMAN | PARP1 | physical | 24886089 | |
| PAR14_HUMAN | PARP14 | physical | 24886089 | |
| DTX3L_HUMAN | DTX3L | physical | 24886089 | |
| STAT1_HUMAN | STAT1 | physical | 26479788 | |
| DTX3L_HUMAN | DTX3L | physical | 26479788 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...